Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 141,656 shares at $30.31 ($4.3M) on 2021-09-09, disclosed to the SEC on 2021-09-13.
Open-market sale of $4.3M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.31 | 14,329 | $434K | 10.1% |
| 2 | $30.31 | 14,329 | $434K | 10.1% |
| 3 | $30.44 | 38,056 | $1.2M | 26.9% |
| 4 | $30.44 | 38,056 | $1.2M | 26.9% |
| 5 | $31.03 | 5,171 | $160K | 3.7% |
| 6 | $31.03 | 5,171 |
| $160K |
| 3.7% |
| 7 | $30.20 | 13,272 | $401K | 9.3% |
| 8 | $30.20 | 13,272 | $401K | 9.3% |
| Total | $30.41 avg | 141,656 | $4.3M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |